MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-22-0013005
Abbares Pharmaceuticals Private Limited - pharma in Jodhpur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹34.8 Cr
▲ 6% YoY
Net profit · FY 2025
₹61.23 Lakh
Net margin 1.8%
EBITDA · FY 2025
₹1.33 Cr
EBITDA margin 3.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹4.23 Cr
Satisfied ₹4.47 Cr
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Abbares Pharmaceuticals Private Limited
Data last updated:
Abbares Pharmaceuticals Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2018PTC060761. Its GSTIN is 08AAQCA7250B1ZQ (Rajasthan).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rajesh Bhardwaj and Preksha Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Villa No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.8 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹61.23 Lakh (net margin 1.8%) and EBITDA of ₹1.33 Cr (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹4.23 Cr and satisfied charges of ₹4.47 Cr on record.
Abbares Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-22-0013005). For more details, the company can be reached via its website abbarespharma.com.
Company details
CIN U51909RJ2018PTC060761
Registration Number 060761
Incorporation Date 31 March 2018
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-RJ-22-0013005
Recognitions & Rankings of Abbares Pharmaceuticals
Contact details
Abbares Pharmaceuticals Private Limited's registered office is in Jodhpur, Rajasthan. Its website is abbarespharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVilla No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Abbares Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Abbares Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Abbares Pharmaceuticals Private Limited
FY 2025 filings availableAbbares Pharmaceuticals Private Limited reported revenue of ₹34.8 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹34.8 Cr ▲ 6%
Net profit · FY 2025
₹61.23 Lakh margin 1.8%
EBITDA · FY 2025
₹1.33 Cr margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 5%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 26%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 6% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹61.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abbares Pharmaceuticals Private Limited, buy the company report.
Board of directors of Abbares Pharmaceuticals Private Limited
Abbares Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Bhardwaj | Director | 31 Mar 2018 | 8 Years 6 Months | Current |
| Preksha Bhardwaj | Director | 15 Jun 2019 | 7 Years 4 Months | Current |
| Seema Bhardwaj | Director | 01 Nov 2021 | 4 Years 11 Months | Current |
Auditor
Abbares Pharmaceuticals Private Limited is audited by Vinod Kumar Mehta for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vinod Kumar Mehta | FY 2023 | 071599 |
Shareholding
The shareholding of Abbares Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Abbares Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.23 Cr
Satisfied charges
₹4.47 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Nov 2023 | 100844174 | Others | ₹3.5 Cr | Open | |
| 18 Oct 2022 | 100622588 | Others | ₹68 Lakh | Open | |
| 21 Dec 2021 | 100519975 | Hdfc Bank Limited | ₹5.06 Lakh | Open | |
| 30 Sep 2022 | 100618580 | Others | ₹2.97 Cr | Satisfied | |
| 29 Jan 2021 | 100420556 | Hdfc Bank Limited | ₹1.2 Cr | Satisfied |
To see the full charge records of Abbares Pharmaceuticals Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
No court or tribunal cases involving Abbares Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abbares Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Abbares Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAQCA7250B1ZQ | Rajasthan | Active | 13 Apr 2018 |
To see the full GST registrations and return filing status of Abbares Pharmaceuticals Private Limited, buy the company report.
Recent activity
Abbares Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Seema Bhardwaj was appointed as Director on 01 Nov 2021.
AGM
Abbares Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Abbares Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge registered on 23 Jan 2019 via Charge ID 100239394 with Others was fully satisfied on 15 Mar 2024.
Charges
A charge with Others of Rs. 350.00 Lakh registered on 20 Nov 2023 with Charge ID 100844174 was modified on 01 Mar 2024.
Charges
A charge registered on 30 Sep 2022 via Charge ID 100618580 with Others was fully satisfied on 27 Feb 2024.
Charges
A charge registered on 29 Jan 2021 via Charge ID 100420556 with Hdfc Bank Limited was fully satisfied on 02 Feb 2024.
Charges
A charge with Others amounted to Rs. 350.00 Lakh with Charge ID 100844174 was registered on 20 Nov 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 120.00 Lakh registered on 29 Jan 2021 with Charge ID 100420556 was modified on 23 Nov 2022.
Charges
A charge registered on 11 Nov 2019 via Charge ID 100307785 with Others was fully satisfied on 16 Nov 2022.
Charges
A charge registered on 25 Oct 2019 via Charge ID 100304469 with Others was fully satisfied on 11 Nov 2022.
Charges
A charge registered on 24 Oct 2019 via Charge ID 100304465 with Others was fully satisfied on 11 Nov 2022.
Charges
A charge with Others amounted to Rs. 68.00 Lakh with Charge ID 100622588 was registered on 18 Oct 2022.
15 earlier events are in the company report.
Frequently asked questions
Abbares Pharmaceuticals is an active private limited company based in Jodhpur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 2018 (8+ years old) and is registered under CIN U51909RJ2018PTC060761.
Abbares Pharmaceuticals has 3 current directors:
- Rajesh Bhardwaj - Director
- Preksha Bhardwaj - Director
- Seema Bhardwaj - Director
The latest financial statements of Abbares Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Abbares Pharmaceuticals is 08AAQCA7250B1ZQ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Abbares Pharmaceuticals is U51909RJ2018PTC060761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abbares Pharmaceuticals was incorporated on 31 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Jaipur.
Seema Bhardwaj was appointed as Director on 01 Nov 2021. Subodh Saxena ceased to be Director on 20 Mar 2020. Preksha Bhardwaj ceased to be Additional Director on 30 Sep 2019. Abbares Pharmaceuticals has 5 board changes on record in total.
Yes, Abbares Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-22-0013005).
Abbares Pharmaceuticals can be reached through the website abbarespharma.com. Its registered office is in Jodhpur, Rajasthan, India.
The registered office of Abbares Pharmaceuticals is at Villa No 14 Umaid Haritage Ratanada, Jodhpur, Rajasthan, India – 342011.